Mice lacking the α4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function

Molecular Pharmacology

Volumn 68, Issue 5, 2005, Pages 1376-1386

  Parish, C L ^a   Nunan, J ^a   Finkelstein, D I ^a   McNamara, F N ^b   Wong, J Y ^a   Waddington, J L ^b   Brown, R M ^a   Lawrence, A J ^a   Horne, M K ^a   Drago, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 NICOTINIC RECEPTOR; AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; NICOTINE; NICOTINIC RECEPTOR; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CHRNB4 PROTEIN, MOUSE; DRUG DERIVATIVE; NERVE PROTEIN; OXIDOPAMINE;

ALPHA CHAIN; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; KNOCKOUT MOUSE; LONG TERM EXPOSURE; MOUSE; NERVE ENDING; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SUBSTANTIA NIGRA; SYNAPTOSOME; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; CELL COUNT; CORPUS STRIATUM; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; COCAINE; CORPUS STRIATUM; DOPAMINE; MICE; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 27544471136     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.104.004820     Document Type: Article

References (40)

1. Benoit-Marand M, Jaber M, and Gonon F (2000) Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur J Neurosci 12:2985-2992.
2. Braendgaard H, Evans SM, Howard CV, and Gundersen HJ (1990) The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J Microsc 157:285-304.
3. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, Clementi F, Moretti M, Rossi FM, Le Novere N, et al. (2003) Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knockout mice. J Neurosci 23:7820-7829.
4. Drago J, McColl CD, Horne MK, Finkelstein DI, and Ross SA (2003) Neuronal nicotinic receptors: insights gained from gene knockout and knockin mutant mice. Cell Mol Life Sci 60:1267-1280.
5. Drew AE and Werling LL (2003) Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine. Schizophr Res 65:47-55.
6. el-Bizri H and Clarke PB (1994) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br J Pharmacol 111:406-413.
7. Fenster CP, Beckman ML, Parker JC, Sheffield EB, Whitworth TL, Quick MW, and Lester RA (1999) Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol Pharmacol 55:432-443.
8. Finkelstein DI, Stanic D, Parish CL, Tomas D, Dickson K, and Horne MK (2000) Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97:99-112.
9. Gerasimov MR, Franceschi M, Volkow ND, Rice O, Schiffer WK, and Dewey SL (2000) Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 38:432-437.
10. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, et al. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881.
11. Hart C and Ksir C (1996) Nicotine effects on dopamine clearance in rat nucleus accumbens. J Neurochem 66:216-221.
12. Hill JA Jr, Zoli M, Bourgeois JP, and Changeux JP (1993) Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit. J Neurosci 13:1551-1568.
13. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, and Caron MG (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95:4029-4034.
14. Le Novere N, Zoli M, and Changeux JP (1996) Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8:2428-2439.
15. Li S, Kim KY, Kim JH, Park MS, Bahk JY, and Kim MO (2004) Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain. Neurosci Lett 363:29-32.
16. Marshall DL, Redfern PH, and Wonnacott S (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511-1519.
17. Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, McIntosh JM, Rossi F, Champtiaux N, Zoli M, et al. (2003) Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17:1329-1337.
18. McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, and Lawrence AJ (2003) Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28:1472-1484.
19. McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Croke DT, and Waddington JL (2003) Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. Neuropsychopharmacology 28:86-99.
20. 3 dopamine receptor "knockout". Synapse 46:19-31.
21. Melikian HE and Buckley KM (1999). Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19:7699-7710.
22. Middleton LS, Cass WA, and Dwoskin LP (2004) Nicotinic receptor modulation of dopamine transporter function in rat striatum and medial prefrontal cortex. J Pharmacol Exp Ther 308:367-377.
23. Nisell M, Nomikos GG, and Svensson TH (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36-44.
24. Pacheco MA, Pastoor TE, and Wecker L (2003) Phosphorylation of the alpha4 subunit of human alpha4beta2 nicotinic receptors: role of cAMP-dependent protein kinase (PKA) and protein kinase C (PKC). Brain Res Mol Brain Res 114:65-72.
25. Padungchaichot P, Wong JY, Natoli AL, Massalas JS, Finkelstein DI, Lawrence AL, and Drago J (2000) Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons. Neuroscience 95:1025-1033.
26. Parish CL, Finkelstein DI, Drago J, Borrelli E, and Horne MK (2001) The role of dopamine receptors in regulating the size of axonal arbors. J Neurosci 21:5147-5157.
27. Parish CL, Finkelstein DI, Tripanichkul W, Satoskar AR, Drago J, and Horne MK (2002a) The role of interleukin-1, interleukin-6 and glia in inducing growth of neuronal terminal arbors in mice. J Neurosci 22:8034-8041.
28. Parish CL, Stanic D, Drago J, Borrelli E, Finkelstein DI, and Horne MK (2002b) Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. Eur J Neurosci 16:787-794.
29. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK, Scheffer IE, Kola I, Waddington JL, Berkovic SF, et al. (2000) Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 20:6431-6441.
30. Sacaan AI, Dunlop JL, and Lloyd GK (1995) Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J Pharmacol Exp Ther 274:224-230.
31. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, and Grady SR (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65:1526-1535.
32. 3H]-dopamine release from rat striatal synaptosomes. Br J Pharmacol 132:785-791.
33. Stanic D, Finkelstein DI, Bourke DW, Drago J, and Horne MK (2003a) Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat. Eur J Neurosci 18:1175-1188.
34. Stanic D, Parish CL, Zhu WM, Krstew EV, Lawrence AJ, Drago J, Finkelstein DI, and Horne MK (2003b) Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. J Neurochem 86:329-343.
35. Sun X, Liu Y, Hu G, and Wang H (2004) Activities of cAMP-dependent protein kinase and protein kinase C are modulated by desensitized nicotinic receptors in the rat brain. Neurosci Lett 367:19-22.
36. Tripanichkul W, Stanic D, Drago J, Finkelstein DI, and Horne MK (2003) D2 Dopamine receptor blockade results in sprouting of DA axons in the intact animal but prevents sprouting following nigral lesions. Eur J Neurosci 17:1033-1045.
37. Wonnacott S, Irons J, Rapier C, Thorne B, and Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res 79:157-163.
38. Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, and Hen R (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 98:1982-1987.
39. Zoli M, Lena C, Picciotto MR, and Changeux JP (1998) Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 18:4461-4472.
40. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, and Gotti C (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22:8785-8789.